[An acellular pertussis vaccine based on the natural complex of antigens isolated from the supernatant of a synthetic culture medium]. - Suppr | 超能文献

[An acellular pertussis vaccine based on the natural complex of antigens isolated from the supernatant of a synthetic culture medium].

作者信息

Zakharova N S, Remova T N, Bazhanova I G, Ozeretskovskaia M H, Britsina M V, Shmeleva E I, Mertsalova N U, Ermolova E I, Sukhinova E E, Bulk V F, Sirotinskiĭ A V, Poluiianova A G, Sviridov V V, Vartanian Iu P

出版信息

Zh Mikrobiol Epidemiol Immunobiol. 1997 May-Jun(3):67-70.

Abstract

A highly effective technology for obtaining a protective antigenic complex, including the main Bordetella pertussis protective antigens (pertussis toxin, filamentous hemagglutinin, agglutinogens, pertactin and adenylate cyclase) and isolated from the supernatant of B. pertussis cultivation medium, has been developed. A new method for the detoxication of antigenic complex which more available to preserve the protective property was suggested. Experimental batches of monovaccine and adsorbed DPT vaccine with the acellular pertussis component, possessing high protective activity and low histamine-sensitizing properties, have been obtained. The stability of protective properties both in liquid and lyophilized acellular pertussis preparations has been noted.

摘要

相似文献

1

[An acellular pertussis vaccine based on the natural complex of antigens isolated from the supernatant of a synthetic culture medium].

Zh Mikrobiol Epidemiol Immunobiol. 1997 May-Jun(3):67-70.

2

[A polyvalent complex of Bordetella pertussis antigens as the basis for an acellular pertussis vaccine].

Zh Mikrobiol Epidemiol Immunobiol. 1997 May-Jun(3):70-2.

3

[Characteristics of the biological properties of a cell-free pertussis preparation].

Zh Mikrobiol Epidemiol Immunobiol. 1987 Jun(6):38-43.

4

Effect of priming with diphtheria and tetanus toxoids combined with whole-cell pertussis vaccine or with acellular pertussis vaccine on the safety and immunogenicity of a booster dose of an acellular pertussis vaccine containing a genetically inactivated pertussis toxin in fifteen- to twenty-one-month-old children. Italian Multicenter Group for the Study of Recombinant Acellular Pertussis Vaccine.

J Pediatr. 1995 Aug;127(2):238-43. doi: 10.1016/s0022-3476(95)70301-2.

5

Immunogenicity and protective efficacy of a newly developed tri-component diphtheria, tetanus, and acellular pertussis vaccine in a murine model.

J Microbiol Immunol Infect. 2018 Dec;51(6):732-739. doi: 10.1016/j.jmii.2017.04.003. Epub 2017 Jun 29.

6

A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis. Progetto Pertosse Working Group.

N Engl J Med. 1996 Feb 8;334(6):341-8. doi: 10.1056/NEJM199602083340601.

7

[The expression of Bordetella pertussis protective antigens during bacterial multiplication on a medium with a fixed chemical composition].

Zh Mikrobiol Epidemiol Immunobiol. 1997 Mar-Apr(2):47-50.

8

Assessment of safety and efficacy against Bordetella pertussis of a new tetanus-reduced dose diphtheria-acellular pertussis vaccine in a murine model.

BMC Infect Dis. 2017 Apr 4;17(1):247. doi: 10.1186/s12879-017-2369-x.

9

[Physicochemical and biological characteristics of preparations of an antigenic complex isolated from the cultivation medium of Bordetella pertussis].

Zh Mikrobiol Epidemiol Immunobiol. 1988 Aug(8):76-9.

10

Effect of injection site on reactogenicity and immunogenicity of acellular and whole-cell pertussis component diphtheria-tetanus-pertussis vaccines in infants.

Vaccine. 2005 Oct 17;23(43):5106-12. doi: 10.1016/j.vaccine.2005.05.039.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。